Alumis
$28.66
22
+$1.43+5.25% Friday 20:00
+$0.48+1.67%Friday 23:35After hours
Statistics
Day High
28.73
Day Low
28.65
52W High
31.35
52W Low
3.25
Volume
39,055
Avg. Volume
-
Mkt Cap
3.65B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-1.82
-0.96
-0.09
0.77
Expected EPS
-0.722727
Actual EPS
N/A
Financials
-1,011.75%Profit Margin
Unprofitable24.05MRevenue
-243.33MNet Income
Analyst Ratings
39.71Average Price Target
The highest estimate is 51.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy 86%
Hold 14%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ALMS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. Alumis Inc. was incorporated in 2021 and is headquartered in South San Francisco, California.
Show more...
CEO
Mr. Martin Babler Ph.D.
Employees
223
Country
United States
ISIN
US0223071020
Listings
0 Comments
Share your thoughts
FAQ
What is Alumis stock price today?▼
The current price of ALMS is $28.66 USD — it has increased by +5.25% in the past 24 hours. Watch Alumis stock price performance more closely on the chart.
What is Alumis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Alumis stocks are traded under the ticker ALMS.
Is Alumis stock price growing?▼
ALMS stock has risen by +1.24% compared to the previous week, the month change is a +22.43% rise, over the last year Alumis has showed a +760.66% increase.
What is Alumis market cap?▼
Today Alumis has the market capitalization of 3.65B
When is the next Alumis earnings date?▼
Alumis is going to release the next earnings report on August 19, 2026.
What were Alumis earnings last quarter?▼
ALMS earnings for the last quarter are -0.74 USD per share, whereas the estimation was -0.74 USD resulting in a +0.37% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Alumis revenue for the last year?▼
Alumis revenue for the last year amounts to 24.05M USD.
What is Alumis net income for the last year?▼
ALMS net income for the last year is -243.33M USD.
How many employees does Alumis have?▼
As of July 19, 2026, the company has 223 employees.
In which sector is Alumis located?▼
Alumis operates in the Health & Wellness sector.
When did Alumis complete a stock split?▼
Alumis has not had any recent stock splits.
Where is Alumis headquartered?▼
Alumis is headquartered in South San Francisco, United States.